Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics

Sost haploinsufficiency provokes peracute lethal cardiac tamponade without rescuing the osteopenia in a mouse model of excess glucocorticoids

(2019) Behzad Javaheri et al.   AMERICAN JOURNAL OF PATHOLOGY

Bone metabolism markers are associated with neck circumference in adult Arab women

(2019) R.S. Albassam et al.   OSTEOPOROSIS INTERNATIONAL

Human Genetics and Drug Development

(2019) Michael V. Holmes   NEW ENGLAND JOURNAL OF MEDICINE

Gene expression imputation across multiple brain regions provides insights into schizophrenia risk

(2019) Laura M. Huckins et al.   NATURE GENETICS

Osteoporosis

(2019) Juliet E Compston et al.   LANCET

Abundant associations with gene expression complicate GWAS follow-up

(2019) Boxiang Liu et al.   NATURE GENETICS

Mendelian Randomization Analysis Reveals a Causal Influence of Circulating Sclerostin Levels on Bone Mineral Density and Fractures

(2019) Jie Zheng et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Genetically regulated gene expression underlies lipid traits in Hispanic cohorts

(2019) Angela Andaleon et al.   PLoS One

RoB 2: a revised tool for assessing risk of bias in randomised trials

(2019) Jonathan A C Sterne et al.   BMJ-British Medical Journal

Computational and functional characterization of four SNPs in the SOST locus associated with osteoporosis

(2018) Weiyuan Ye et al.   BONE

A Phase 3 Randomized Placebo-controlled Trial to Evaluate Efficacy and Safety of Romosozumab in Men With Osteoporosis

(2018) E Michael Lewiecki et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Genetics of Sost/SOST in sclerosteosis and van Buchem disease animal models

(2018) Aimy Sebastian et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes

(2018) Rainer Malik et al.   NATURE GENETICS

Shared genetic effects on chromatin and gene expression indicate a role for enhancer priming in immune response

(2018) Kaur Alasoo et al.   NATURE GENETICS

Sclerostin in chronic kidney disease–mineral bone disorder think first before you block it!

(2018) Vincent M Brandenburg et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Circulating levels of sclerostin are associated with cardiovascular mortality

(2018) Cristina Novo-Rodríguez et al.   PLoS One

Formalising recall by genotype as an efficient approach to detailed phenotyping and causal inference

(2018) Laura J. Corbin et al.   Nature Communications

Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians

(2018) Neil M Davies et al.   BMJ-British Medical Journal

Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians

(2018) Neil M Davies et al.   BMJ-British Medical Journal

Association of CETP Gene Variants With Risk for Vascular and Nonvascular Diseases Among Chinese Adults

(2018) Iona Y. Millwood et al.   JAMA Cardiology

Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies

(2018) Stephen Burgess et al.   JAMA Cardiology

Meta-analysis of genome-wide association studies for body fat distribution in 694,649 individuals of European ancestry

(2018) Sara L Pulit et al.   HUMAN MOLECULAR GENETICS

Biobank-driven genomic discovery yields new insight into atrial fibrillation biology

(2018) Jonas B. Nielsen et al.   NATURE GENETICS

Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits

(2018) Evangelos Evangelou et al.   NATURE GENETICS

Assessment of the genetic and clinical determinants of fracture risk: genome wide association and mendelian randomisation study

(2018) Katerina Trajanoska et al.   BMJ-British Medical Journal

Serum levels of sclerostin as a potential biomarker in central arterial stiffness among hypertensive patients

(2018) Yu-Chi Chang et al.   BMC Cardiovascular Disorders

The UK Biobank resource with deep phenotyping and genomic data

(2018) Clare Bycroft et al.   NATURE

An atlas of genetic influences on osteoporosis in humans and mice

(2018) John A. Morris et al.   NATURE GENETICS

Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps

(2018) Anubha Mahajan et al.   NATURE GENETICS

Serum sclerostin and irisin as predictive markers for atherosclerosis in Egyptian type II diabetic female patients: A case control study

(2018) Mona Kamal Saadeldin et al.   PLoS One

Alterations in bone turnover markers in patients with noncardio-embolic ischemic stroke

(2018) K. Mathold et al.   PLoS One

Phenome-wide association studies across large population cohorts support drug target validation

(2018) Dorothée Diogo et al.   Nature Communications

Cathepsin K Inhibitors for Osteoporosis: Biology, Potential Clinical Utility, and Lessons Learned

(2017) Matthew T Drake et al.   ENDOCRINE REVIEWS

How to use Mendelian randomization to anticipate the results of randomized trials

(2017) Brian A Ference   EUROPEAN HEART JOURNAL

Improved imputation accuracy of rare and low-frequency variants using population-specific high-coverage WGS-based imputation reference panel

(2017) Mario Mitt et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

Mendelian randomization: a novel approach for the prediction of adverse drug events and drug repurposing opportunities

(2017) Venexia M Walker et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Triangulation in aetiological epidemiology

(2017) Debbie A. Lawlor et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Efficacy of anti-sclerostin monoclonal antibody BPS804 in adult patients with hypophosphatasia

(2017) Lothar Seefried et al.   JOURNAL OF CLINICAL INVESTIGATION

Genetic effects on gene expression across human tissues

(2017) François Aguet et al.   NATURE

Identification of 153 new loci associated with heel bone mineral density and functional involvement of GPC6 in osteoporosis

(2017) John P Kemp et al.   NATURE GENETICS

Association analyses based on false discovery rate implicate new loci for coronary artery disease

(2017) Christopher P Nelson et al.   NATURE GENETICS

Romosozumab — Promising or Practice Changing?

(2017) Clifford J. Rosen   NEW ENGLAND JOURNAL OF MEDICINE

Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis

(2017) Kenneth G. Saag et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sclerostin influences body composition by regulating catabolic and anabolic metabolism in adipocytes

(2017) Soohyun P. Kim et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Contribution of industry funded post-marketing studies to drug safety: survey of notifications submitted to regulatory agencies

(2017) Angela Spelsberg et al.   BMJ-British Medical Journal

Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis

(2017) Eleanor Wheeler et al.   PLOS MEDICINE

Contribution of industry funded post-marketing studies to drug safety: survey of notifications submitted to regulatory agencies

(2017) Angela Spelsberg et al.   BMJ-British Medical Journal

Osteoporosis treatment: recent developments and ongoing challenges

(2017) Sundeep Khosla et al.   Lancet Diabetes & Endocrinology

PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study

(2017) Amand F Schmidt et al.   Lancet Diabetes & Endocrinology

1000 Genomes-based meta-analysis identifies 10 novel loci for kidney function

(2017) Mathias Gorski et al.   Scientific Reports

Wnt Signaling Pathway Inhibitor Sclerostin Inhibits Angiotensin II–Induced Aortic Aneurysm and AtherosclerosisHighlights

(2016) Smriti Murali Krishna et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Bisphosphonates for cardiovascular risk reduction: A systematic review and meta-analysis

(2016) Guido Kranenburg et al.   ATHEROSCLEROSIS

Analysis of protein-coding genetic variation in 60,706 humans

(2016) Monkol Lek et al.   NATURE

A reference panel of 64,976 haplotypes for genotype imputation

(2016)   NATURE GENETICS

Romosozumab Treatment in Postmenopausal Women with Osteoporosis

(2016) Felicia Cosman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Postmenopausal Osteoporosis

(2016) Dennis M. Black et al.   NEW ENGLAND JOURNAL OF MEDICINE

A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease

(2016) Robert A. Scott et al.   Science Translational Medicine

Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function

(2016) Cristian Pattaro et al.   Nature Communications

Methylation of BoneSOST, Its mRNA, and Serum Sclerostin Levels Correlate Strongly With Fracture Risk in Postmenopausal Women

(2015) Sjur Reppe et al.   JOURNAL OF BONE AND MINERAL RESEARCH

A Randomized, Double-Blind Phase 2 Clinical Trial of Blosozumab, a Sclerostin Antibody, in Postmenopausal Women with Low Bone Mineral Density

(2015) Robert R. Recker et al.   JOURNAL OF BONE AND MINERAL RESEARCH

HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials

(2015) Daniel I Swerdlow et al.   LANCET

New genetic loci link adipose and insulin biology to body fat distribution

(2015) Dmitry Shungin et al.   NATURE

Genetic studies of body mass index yield new insights for obesity biology

(2015) Adam E. Locke et al.   NATURE

Whole‐genome sequencing identifies EN1 as a determinant of bone density and fracture

(2015) Hou‐Feng Zheng et al.   NATURE

A comprehensive 1000 Genomes–based genome-wide association meta-analysis of coronary artery disease

(2015) Majid Nikpay et al.   NATURE GENETICS

Novel insights into the genetics of smoking behaviour, lung function, and chronic obstructive pulmonary disease (UK BiLEVE): a genetic association study in UK Biobank

(2015) Louise V Wain et al.   Lancet Respiratory Medicine

Feature Selection with theBorutaPackage

(2015) Miron B. Kursa et al.   Journal of Statistical Software

Bisphosphonates and Risk of Cardiovascular Events: A Meta-Analysis

(2015) Dae Hyun Kim et al.   PLoS One

Romosozumab in Postmenopausal Women with Osteopenia

(2014)   NEW ENGLAND JOURNAL OF MEDICINE

Romosozumab in Postmenopausal Women with Low Bone Mineral Density

(2014) Michael R. McClung et al.   NEW ENGLAND JOURNAL OF MEDICINE

Is animal research sufficiently evidence based to be a cornerstone of biomedical research?

(2014) P. Pound et al.   BMJ-British Medical Journal

Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics

(2014) Claudia Giambartolomei et al.   PLoS Genetics

Genetics of coronary artery calcification among African Americans, a meta-analysis

(2013) Mary K Wojczynski et al.   BMC Medical Genetics

RANKL Inhibition With Denosumab Does Not Influence 3-Year Progression of Aortic Calcification or Incidence of Adverse Cardiovascular Events in Postmenopausal Women With Osteoporosis and High Cardiovascular Risk

(2013) Elizabeth J Samelson et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Sclerostin: Another Vascular Calcification Inhibitor?

(2013) Kathleen J. Claes et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Secretory Phospholipase A 2 -IIA and Cardiovascular Disease

(2013) Michael V. Holmes et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Discovery and refinement of loci associated with lipid levels

(2013) Cristen J Willer et al.   NATURE GENETICS

Validating therapeutic targets through human genetics

(2013) Robert M. Plenge et al.   NATURE REVIEWS DRUG DISCOVERY

Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study

(2013) Vincent M Brandenburg et al.   BMC Nephrology

A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance

(2012) Alisa K Manning et al.   NATURE GENETICS

Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits

(2012) Jian Yang et al.   NATURE GENETICS

Coexistence of osteoporosis (OP) and coronary artery disease (CAD) in the elderly: It is not just a by chance event

(2011) Yusuf Yesil et al.   ARCHIVES OF GERONTOLOGY AND GERIATRICS

The Regulation of Valvular and Vascular Sclerosis by Osteogenic Morphogens

(2011) Kristina I. Boström et al.   CIRCULATION RESEARCH

China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up

(2011) Z. Chen et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants

(2011) L. D. Ward et al.   NUCLEIC ACIDS RESEARCH

Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women—the six-month effect of risedronate and teriparatide

(2011) S. A. Polyzos et al.   OSTEOPOROSIS INTERNATIONAL

The Appearance and Modulation of Osteocyte Marker Expression during Calcification of Vascular Smooth Muscle Cells

(2011) Dongxing Zhu et al.   PLoS One

Robust relationship inference in genome-wide association studies

(2010) Ani Manichaikul et al.   BIOINFORMATICS

Low density lipoprotein receptor-related protein 5 (LRP5) mutations and osteoporosis, impaired glucose metabolism and hypercholesterolaemia

(2009) Anne Saarinen et al.   CLINICAL ENDOCRINOLOGY